The new pro-weed atmosphere in America has brought about an age of discovery. Where cannabis research and the exploration of its effects were previously hampered by savage marijuana prohibition, today those fascinated by the plant can crack it open in a lab setting and hone our understanding of it.
Many primary questions about cannabis focus on its interaction with our bodies, particularly our brains. Each of the dozens of cannabinoids may have a unique effect on us, and we’re just barely scratching the surface. With a little patience and a lot of research, we’ll soon have some answers about the complexities of cannabis. However, I recently learned of a company that makes it feel like the future of cannabis is already here.
Potbotics specializes in applying technologies like brain scanning and artificial intelligence to diagnostics for patients and cannabis plants alike. The most fascinating product is BrainBot, an electroencephalography scan that monitors your neural reactions to certain strains and compounds so you can figure out which strain effects you in which way. The idea is that you can target specific reactions and give patients exactly the strain they need. Another, NanoPot, scans seeds for their DNA information and recommends optimal growth strategies based on the findings.
Naturally, my first question when I met founder David Goldstein was, “Can you please scan my brain while we get high right now?” But I’ll have to wait just a little longer before I can literally see pictures of my stoned brain. In the meantime, David shared his views on legalization and how it’s affecting his foray into the tech side of pot.